DrugInformations.org

A study published in the open-access journal PLoS Medicinehas found that women in the developing world are not getting thecervical cancer screenings that they need. Researcher Emmanuela Gakidou(University of Washington, Seattle, USA) and colleagues report thatalthough women in the developing world have the highest risk ofdeveloping cervical cancer, few are effectively screened.

More: continued here

No Comments »

The contract to provide the vaccine against HPV (human papillomavirus), was awarded by the Department of Health to pharmaceutical company GlaxoSmithKline for their vaccine ‘Cervarix’. The contract is to supply the vaccine that protects against cervical cancer and pre-cancerous cell changes in the cervix caused by HPV viruses.

More: continued here

No Comments »

Reacting to today’s announcement that the Department of Health is going to use the Cervarix HPV vaccine, that protects young women against cervical cancer in their nationwide vaccination programme, Julie Bentley, Chief Executive fpa said: “While we of course welcome the introduction

More: continued here

No Comments »

Responding to the announcement by the Department of Health of details of the human papillomavirus (HPV) vaccination programme Simon Blake, Chief Executive of Brook, said: “Brook welcomes confirmation of the details of the HPV vaccination programme from September 2008 that will offer all girls aged 12-13 years vaccination against HPV viruses 16 and 18, the types that lead to increased risk of cervical cancer.

More: continued here

No Comments »

The tender decision made by the UK authorities choosing a two-type (16/18) HPV vaccine for their immunisation campaign means that the girls in this campaign will not benefit from the world’s leading four-type (6,11,16,18) HPV vaccine, Gardasil®.

More: continued here

No Comments »

The British Association for Sexual Health and HIV (BASHH) today expressed disappointment that the Government has missed the opportunity to eradicate a common STI, genital warts, from the medical map, as today’s announcement by the Department of Health on the human papillomavirus vaccine (HPV), “Department of Health awards contract for HPV vaccine”, saw GlaxoSmithKline’s vaccine Ceravix awarded the Government contract.

More: continued here

No Comments »

QIAGEN was featured this week for its efforts to eliminate cervical cancer at the 14th annual Global Summit of Women in Hanoi, Vietnam. CEO Peer Schatz came to this prominent international platform to issue a call to other leaders in business, NGOs and governments to join him and campaign to create a cervical-cancer-free world.

More: continued here

No Comments »

Merck recently launched a cinema advertising campaign for its human papillomavirus vaccine Gardasil during the opening of the film “Sex and the City,” the Newark Star-Ledger reports. The campaign features a 60-second ad similar to the company’s “I Chose” television commercial.

More: continued here

No Comments »

Safety concerns over Merck’s human papillomavirus vaccine Gardasil are unfounded, and reports of serious adverse events are unrelated to the vaccine, CDC officials recently said, the Dallas Morning News reports.

More: continued here

No Comments »

Gen-Probe Incorporated (Nasdaq: GPRO) announced that the Company has launched in Europe its APTIMA(R) HPV Assay, a highly specific molecular diagnostic test to detect high-risk strains of the human papillomavirus (HPV), which causes cervical cancer. The APTIMA HPV Assay has been CE marked and is currently available for sale in 13 European Union countries.

More: continued here

No Comments »